On April 1, the Hang Seng Biotech Index surged 6.78% in a single day, followed by another 0.89% gain on April 2, closing at 15,641. From the ETF side, funds tracking healthcare and biotech moved higher in sync with the index. $CAM HSBIOTECH(03069)$ rose 0.58%, $CSOP HSBIOTECH(03174)$ gained 0.92%, and $GX CN BIOTECH(02820)$ increased 1.17%, showing a consistent upward trend alongside the broader sector. Capital allocation into passive products is also picking up. At the stock level, $HANSOH PHARMA(03692)$ rose 5.18%, $INNOCARE(09969)$ gained 4.44%,
Mixed Opening of Hong Kong Stocks with Notable Movements in Tech and Biomedicine Sectors on April 2, 2026
On April 2, 2026, the Hong Kong stock market opened lower with the Hang Seng Index down 0.16% and the Hang Seng China Enterprises Index down 0.32%. Key tech stocks like Tencent and Alibaba fell over 1%, while Shandong Molong and Montage Tech saw significant gains. The biomedicine and aluminum sectors showed strong performance, indicating mixed investor sentiment at market open.